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The role of blood flow in regulating signaling pathways and gene expression in the blood vasculature is well known.
Recent studies have identified equally important roles of flow-mediated signaling in the lymphatic circulation including
control of lymphatic vascular growth, remodeling, regeneration and maintenance of the lymphatic fate. In this review,
we summarize these advances focusing on the role of fluid dynamics in control of lymphatic vasculature formation.
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Blood flow generates shear stress that plays critical role in
regulation of vascular growth and remodeling while dis-
turbed shear is central to a number of important vascular
disease processes. Thus, physiological shear forces regulate
expression of transcription factors such as c-Fos and Egr-1,
growth factors (PDGF-A, PDGF-B, TGF-β) and integrins
among other molecules [1-4]. On the other hand, disrupted
blood flow dynamics play a key role in initiation and propa-
gation of atherosclerosis and neointima growth [5-8]. While
flow-mediated effects on vascular biology are well described
little attention, until recently, has been paid to the effects of
fluid flow and shear stress in the lymphatic vasculature.
Lymphatic and blood vasculatures are closely related
but yet distinctly different vascular systems. The lymphatic
vasculature develops from embryonic venous circulation
in a series of well-defined steps that are initiated by a fate
change in a subset of endothelial cells (ECs) in the cardinal
vein that begin expressing lymphatic markers. These
newly defined lymphatic endothelial cells (LECs) then mi-
grate out of the cardinal vein forming jugular lymph sacs
that then sprout, giving rise to the entire lymphatic vascu-
lar network [9].
Unlike the blood vasculature which is a closed system,
lymphatic circulation is open with blind-ended lymph-
atic capillaries serving as an entry point for the intersti-
tial fluid and immune cells that are then transported via* Correspondence: michael.simons@yale.edu
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article, unless otherwise stated.progressively enlarging collecting vessels to the thoracic
duct that then empties into subclavian vein. Furthermore,
while blood flow is propelled by rhythmic contractions of
the heart, mammalian lymphatic circulation is driven by a
combination of hydrostatic forces and skeletal muscle
contraction in the limbs augmented by opening and clos-
ing of lymphatic valves. As a result, the lymphatic flow is
slower and more irregular than blood flow.
Lymphatic vessels serve a variety of roles including
draining interstitial fluid and macromolecules extravasated
from blood vessels and returning them to blood circula-
tion as well as facilitating immune cell trafficking and ab-
sorption of lipids. Therefore, lymphatic circulation is
important for the regulation of interstitial fluid balance,
tissue homeostasis and immune surveillance. Abnormal
development or malfunction of lymphatic vessels is associ-
ated with pathological conditions such as lymphedema,
late-onset obesity, hypertension and cardiovascular dis-
eases including atherosclerosis [10-15].
Although LECs, similarly to blood endothelial cells
(BECs), have the ability to sense flow-mediated signaling,
the role played by this signaling in lymphatic vasculature
development and function is still poorly understood. Re-
cent studies have identified contributions of lymphatic
shear stress signaling to the regulation of lymphatic vas-
cular growth, remodeling and lymphatic fate mainten-
ance that will be the subject of this review.Flow-mediated signaling in lymphatic endothelial cells
In mammals, the lymphatic vasculature is composed of
lymphatic capillaries (also known as initial lymphatics),entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Wang and Simons Vascular Cell 2014, 6:14 Page 2 of 5
http://www.vascularcell.com/content/6/1/14pre-collectors and larger collecting lymphatic vessels.
Lymphatic capillaries are blind-ended structures consist-
ing of a single layer of overlapping ECs that lack pericyte
coverage and have little or no basement membrane [9].
Similar to BECs, LECs can sense flow. When cultured in
3D collagen gels and subjected to interstitial fluid flow
(flow through the junctions into the lumen), LECs show
distinct morphological changes including formation of
long extensions and large vacuoles. In contrast, in BECs,
interstitial fluid flow causes increased networking and
multicellular tubulogenesis [16]. Although LECs and BECs
express some common markers, they possess distinct gene
expression profiles. Interstitial flow mediated different cel-
lular responses in BECs and LECs may attribute to differ-
ent signaling pathways activated by flow in these two cell
types. Interestingly, in response to shear flow (flow down
the lumen of the vessels), LECs do not display changes in
morphology. Instead, they align along the axis of the flow
and down-regulate expression levels of pan-cadherins
leading to reduced LEC barrier function [16]. Taken to-
gether, these data indicate that LECs have the ability to
sense distinct signals mediated by different types of flow
and to respond differentially.
LECs can also detect changes of shear stress magni-
tude and adjust their barrier function accordingly [17].
Increasing shear stress magnitude enhances lymphatic
endothelial barrier function indicated by increased
transendothelial electrical resistance (TER) [17]. Mech-
anistically, Rac1, a small Rho family GTPase, is involved
in the signaling responsible for this process as blockade
of Rac1 activity significantly reduces the enhancement
of lymphatic endothelial barrier function in response to
increased shear stress [17]. It is known that cAMP/PKA
signaling pathway can promote enhanced endothelial
barrier function, which can also activate Rac1 [18-24].
Of note, inhibition of PKA activity did not affect shear
stress-mediated enhancement of lymphatic endothelial
barrier function [17] suggesting that shear-induced acti-
vation of Rac1 is not PKA-dependent.
Flow-regulated lymphatic vasculature growth
Recently, an increasing body of evidence has pointed to an
important role of fluid flow in lymphatic vasculature for-
mation. For example, it has been shown that fluid flow
can work synergistically with growth factors such as VEGF
to promote lymphangiogenesis [25]. In a 3D fibrin gel sys-
tem, in which fibrin gel is mixed with a fibrin-bound form
of VEGF (α2-PI1–8-VEGF121) and LECs which then are pi-
petted into an interstitial flow culture chamber; interstitial
flow enhances the effects of the fibrin-bound VEGF (α2-
PI1–8-VEGF121) in promoting lymphatic network forma-
tion [25]. Notably, in this system, lymphatic structures are
formed in parallel to flow only under the condition of the
combined fibrin-bound VEGF (α2-PI1–8-VEGF121) andinterstitial flow [25]. This result is correlated with intersti-
tial flow induced changes of the extracellular distribution
of soluble matrix metalloproteinases (MMPs) that release
fibrin-bound VEGF (α2-PI1–8-VEGF121) to form a VEGF
gradient [25].
The role of interstitial fluid flow in lymphangiogenesis
has been investigated in vivo using a mouse skin regener-
ation model [26,27]. In this model, a circumferential section
of tail skin is removed midway up the tail resulting in com-
pletely interrupted lymphatic vascular network whereas big
blood vessels remain intact. A diameter-matched silicone
sleeve was placed over the wound and fixed in place to the
intact skin on the proximal and distal edges. 0.3% type I rat
tail collagen solution was injected into the wound under
the sleeve and allowed to gel; this formed a collagen dermal
equivalent (CDE) [26]. During tissue regeneration, intersti-
tial fluid channels are formed in CDE prior to the forma-
tion of lymphatic vessels, which bridge the distal and
proximal portions of the lymphatic vessels in intact tail
skin. Once formed, the channels guide LEC migration and
formation of a functional lymphatic capillary network. Im-
portantly, these processes take place only in the direction of
interstitial flow [26].
In line with these results, reduced interstitial flow during
tissue regeneration results in decreased LEC migration
and lymphatic vasculature formation. VEGF-C administra-
tion fails to induce lymphangiogenesis in this setting [27].
During skin regeneration, MMPs activity and VEGF-C ex-
pression are more pronounced at the upstream than the
downstream of interstitial flow [26]. These data suggest
that MMPs and VEGF-C transport are likely directed by
interstitial fluid flow [26]. Consistent with this hypothesis,
reduced interstitial flow results in significantly increased
sub-dermal MMPs and VEGF-C accumulation [27]. To-
gether, these data suggest that growth factors and prote-
ases transported by interstitial flow may be important for
lymphatic vasculature formation [27].
Interestingly, in the tail skin regeneration model, BEC mi-
gration and vascular network organization in CDE are not
directional [26] indicating that LECs and BECs have differ-
ent genetic programs in response to interstitial fluid flow.
Interstitial fluid also generates pressure, which has re-
cently been shown to be involved in lymphangiogenesis
in mice. In developing mouse embryos, the volume of
fluid in the interstitium is correlated with LEC morpho-
logic changes, proliferation and lymphatic vessel expan-
sion [28]. In response to increased interstitial fluid, LECs
become elongated, show increased proliferation and en-
hanced VEGFR3 tyrosine phosphorylation. In contrast, a
reduction in the amount of interstitial fluid causes the op-
posite effect – reduced LEC proliferation and decreased
VEGFR3 phosphorylation [28]. Although LECs become
elongated in response to changes in the volume of intersti-
tial fluid, this elongation requires a molecular mediator
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observed cellular responses. It appears that β1 integrins
play the role of “mediator” in this process [28]. When the
amount of interstitial fluid is increased, β1 integrins are
activated, which subsequently activates Src Family Kinases
(SFKs) and the activation of SFKs results in tyrosine phos-
phorylation of VEGFR3 [28].
Flow in lymphatic valve development
A recent study has identified lymph flow as a factor that
regulates lymphatic valve development during lymphatic
remodeling [29]. Lymphatic valves form in collecting
lymphatic vessels, thereby preventing back flow of lymph.
This is a complex process that involves a large number of
genes and a variety of intracellular signaling pathways
(reviewed by [30] which include ephrin-B2, Foxc2, Prox1,Figure 1 Fluid flow in lymphatic vasculature development in mice. (A
embryonic day (E)16.0, lymph flow induces Cx37 expression and activates c
luminal valve development. (B) Fluid flow plays a role in lymphatic fate ma
blood and lymphatic vessels in mesentery and, therefore mixing of blood a
vessels in Slp-76 null mice causes the change of lymphatic fate to a venousconnexins, Ang2, and integrin-α9/FN-EIIIA, Sema3A/
NRP1 and calcineurin/NFATc1 signaling [29,31-39].
In mice, lymph flow in mesenteric lymphatic vessels
commences on embryonic day (E) 15.5 and at this time
lymphatic valves have not yet formed [29]. As a result, re-
verse lymph flow does occur in many places, especially at
vessel bifurcations. This flow dynamics induce lymphatic
valve development at ~ E16.0. At that time, lymphatic-
valve-forming cells (LVCs) begin to express high levels of
Prox1 and Foxc2, followed by the induction of Cx37 and
activation of calcineurin/NFATc1 signaling [29] (Figure 1A).
In cultured LECs, oscillatory fluid shear stress (OSS)
that mimics lymph flow reversal occurring prior to
lymphatic valve development, is able to trigger Cx37 ex-
pression and activate calcineurin/NFATc1 signaling as in-
dicated by the nuclear accumulation of the transcription) Flow triggers lymphatic valve development. At approximately
alcineurin/NFATc1 signaling in lymphatic-valve-forming cells initiating
intenance. In mice, loss of Slp-76 results in shunt formation between
nd lymphatic circulation. The presence of blood flow in lymphatic
identity.
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the expression levels of PROX1 and FOXC2.
Upon exposure to OSS, LECs with high levels of PROX1
and FOXC2 accumulate NFATc1 in the nucleus, which
does not occur in LECs expressing low levels of PROX1
and FOXC2. These data suggest that flow-induced shear
stress activates distinct signaling pathways in different
LEC populations [29]. Together, both the in vivo and
in vitro data support the notion that lymph flow is in-
volved in triggering lymphatic valve formation.
Furthermore, it now appears that different types of
flow shear stress result in distinct cell morphology and
actin cytoskeleton organization changes in LECs [29].
When subjected to OSS, LECs adapt a more cuboidal
shape and have increased amounts of short perinuclear
F-actin stress fibers, which are hallmarks of LVCs
in vivo. Upon laminar shear stress (LSS), LECs become
elongated, align in the direction of flow and form stress
fibers, reminiscent of LECs (lymphangion cells) that ex-
press low levels of Prox1 and Foxc2 and are located ad-
jacent to LVCs [29].
Similar to lymphatic vessels, veins also have luminal
valves. Interestingly, both venous and lymphatic valve ECs
share common molecular regulators [40]. For instance,
molecules such as Prox1, ephrin-B2, Vegfr3 and integrin-
α9 that are important for lymphatic valve development are
also expressed in venous valve ECs [40]. These data sug-
gest common signaling pathways are involved in venous
and lymphatic valve formation. Fluid flow mediates dis-
tinct shear forces in veins and in lymphatic vessels. It re-
mains intriguing to investigate the role of flow in venous
valve development and how different shear forces regulate
luminal valve formation in veins and lymphatic vessels
through common molecular regulators.Fluid flow and lymphatic fate maintenance
Fluid flow is also important in the lymphatic fate main-
tenance. SLP-76 is a hematopoietic intracellular signal-
ing protein, which has been shown to be required for
blood and lymphatic vascular separation [41-43]. In
mice, loss of Slp-76 results in the formation of abnormal
connections between blood and lymphatic vessels, and
thus mixing of blood and lymphatic circulation [41-43].
Moreover, mesenteric lymphatic vessels in Slp-76 null
mice lose their lymphatic fate and adapt a venous iden-
tity [43] (Figure 1B). This phenotype has been attributed
to the presence of blood flow in mesenteric lymphatic
vessels in SLP-76 deficient mice and it is not due to a
response to factors in the blood that are not present in
the lymph [43]. These findings highlight the importance
of hemodynamic forces in the maintenance of LEC
identity even though the molecular mechanisms under-
lying this process remain unknown.Conclusions
Recent research advances have largely improved our
knowledge on gene products and signaling pathways in-
volved in lymphatic vascular development and have ex-
panded the list of players that contribute to this process.
An increasing amount of evidence has elevated the im-
portance of fluid flow in the formation of lymphatic vascu-
lature. Although our understanding of the molecular
mechanism(s) underlying flow-regulated lymphatic vascu-
lar development is very limited, the importance of fluid
flow in this process will draw increasing research efforts
and will help to gain further insight into this fascinating
research area.
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